In the present study we aimed to determine whether the two SNPs P389 and P49 of β1AR are relevant in predicting AF, antiarrhythmic drug therapy and flecainide-induced cardioversion in patients with recent onset AF. The gene discussed is ADRB1; the disease is atrial fibrillation.